Literature DB >> 24070810

Effectiveness of nonpharmacologic treatments for acute seasonal allergic conjunctivitis.

Paramdeep S Bilkhu1, James S Wolffsohn2, Shehzad A Naroo1, Louise Robertson3, Roy Kennedy3.   

Abstract

OBJECTIVE: To investigate whether artificial tears and cold compress alone or in combination provide a treatment benefit and whether they were as effective as or could enhance topical antiallergic medication.
DESIGN: Randomized, masked clinical trial. PARTICIPANTS: Eighteen subjects (mean age, 29.5±11.0 years) allergic to grass pollen. INTERVENTION: Controlled exposure to grass pollen using an environmental chamber to stimulate an ocular allergic reaction followed by application of artificial tears (ATs), 5 minutes of cold compress (CC), ATs combined with CC, or no treatment applied at each separate visit in random order. A subset of 11 subjects also had epinastine hydrochloride (EH) applied alone and combined with CC in random order or instillation of a volume-matched saline control. MAIN OUTCOME MEASURES: Bulbar conjunctival hyperemia, ocular surface temperature, and ocular symptoms repeated before and every 10 minutes after treatment for 1 hour.
RESULTS: Bulbar conjunctival hyperemia and ocular symptoms decreased and temperature recovered to baseline faster with nonpharmaceutical treatments compared with no treatment (P <0.05). Artificial tears combined with CC reduced hyperemia more than other treatments (P <0.05). The treatment effect of EH was enhanced by combining it with a CC (P <0.001). Cold compress combined with ATs or EH lowered the antigen-raised ocular surface temperature to less than the pre-exposure baseline. Artificial tear instillation alone or CC combined with ATs or EH significantly reduced the temperature (P <0.05). Cold compress combined with ATs or EH had a similar cooling effect (P >0.05). At all measurement intervals, symptoms were reduced for both EH and EH combined with CC than CC or ATs alone or in combination (P <0.014).
CONCLUSIONS: After controlled exposure to grass pollen, CC and AT treatment showed a therapeutic effect on the signs and symptoms of allergic conjunctivitis. A CC enhanced the use of EH alone and was the only treatment to reduce symptoms to baseline within 1 hour of antigenic challenge. Signs of allergic conjunctivitis generally were reduced most by a combination of a CC in combination with ATs or EH.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24070810     DOI: 10.1016/j.ophtha.2013.08.007

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

Review 1.  Emerging Therapeutics for Ocular Surface Disease.

Authors:  Leonard Bielory; Dovid Schoenberg
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

Review 2.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

3.  Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle-controlled study.

Authors:  Rui-Fen Liu; Xiao-Xuan Wu; Xiao Wang; Jing Gao; Jun Zhou; Qi Zhao
Journal:  Int Forum Allergy Rhinol       Date:  2016-11-21       Impact factor: 3.858

Review 4.  Current Knowledge in Allergic Conjunctivitis.

Authors:  Beatriz Vidal Villegas; Jose Manuel Benitez-Del-Castillo
Journal:  Turk J Ophthalmol       Date:  2021-02-25

5.  Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis.

Authors:  Jiayu Bao; Lei Tian; Yifan Meng; Binge Wu; Jingyi Wang; Jing He; Qiyan Shao; Chengshuo Wang; Ying Jie; Luo Zhang
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

6.  Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief.

Authors:  Warner Carr; Jack Schaeffer; Eric Donnenfeld
Journal:  Allergy Rhinol (Providence)       Date:  2016-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.